Mostrar registro simples

dc.contributor.authorRodríguez Lugo, Diego Andrés
dc.contributor.authorVillamil Castañeda, Lina Paola
dc.contributor.authorLasso Apraez, Javier Iván
dc.contributor.authorGarzón Herazo, Javier Ricardo
dc.contributor.authorCelis Preciado, Carlos Andrés
dc.date.accessioned2022-05-31T15:34:09Z
dc.date.accessioned2023-05-11T15:58:09Z
dc.date.available2022-05-31T15:34:09Z
dc.date.available2023-05-11T15:58:09Z
dc.date.created2021
dc.identifierhttps://revistas.javeriana.edu.co/index.php/vnimedica/article/view/30320
dc.identifier.issn0041-9095
dc.identifier.urihttps://hdl.handle.net/20.500.12032/101776
dc.description.abstractTuberculosis (TB) is and infectious disease with a high mortality and is a great challenge for public health worldwide. Among the problems for its eradication, diagnosis represents a major challenge, particularly in low- and middle-income countries. The X
dc.formatPDFspa
dc.format.mimetypeapplication/pdfspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectTuberculosis
dc.subjectTuberculosis
dc.subjectPulmonary
dc.subjectMolecular Diagnostic Techniques
dc.subjectRifampin
dc.titleXpert MTB/RIF ultra : innovation for diagnosis of tuberculosis


Arquivos deste item

ArquivosTamanhoFormatoVisualização
a4361.pdf360.6Kbapplication/pdfVisualizar/Abrir

Este item aparece na(s) seguinte(s) coleção(s)

Mostrar registro simples

http://creativecommons.org/licenses/by-nc/4.0/
Exceto quando indicado o contrário, a licença deste item é descrito como http://creativecommons.org/licenses/by-nc/4.0/

© AUSJAL 2022

Asociación de Universidades Confiadas a la Compañía de Jesús en América Latina, AUSJAL
Av. Santa Teresa de Jesús Edif. Cerpe, Piso 2, Oficina AUSJAL Urb.
La Castellana, Chacao (1060) Caracas - Venezuela
Tel/Fax (+58-212)-266-13-41 /(+58-212)-266-85-62

Nuestras redes sociales

facebook Facebook

twitter Twitter

youtube Youtube

Asociaciones Jesuitas en el mundo
Ausjal en el mundo AJCU AUSJAL JESAM JCEP JCS JCAP